BIMI Medical Stock Surges After Clocking Over 300% Jump In Q3 Sales - BIMI Intl Medical (NASDAQ:BIMI)

China-based healthcare products and services provider, BIMI International Medical Inc BIMI, reported Q3 sales of $13.78 million from $3.09 million a year ago.
The Company said that the growth was mainly driven by the increase in sales of wholesale pharmaceuticals and the recently-acquired five hospitals.
Revenues from the wholesale pharmaceuticals segment reached $8.4 million. Sales from the medical devices segment reached $1.61 million, and the services segment generated sales of $2.9 million.
The gross profit increased to $2.03 million from $257k reported a year ago.
BIMI reported a Q3 EPS loss of $(0.06) narrower than $(0.19) posted a year ago.
BIMI held cash of $209k and working capital of $2.12 million.
Price Action: BIMI shares are up 63.9% at $1.07 during the premarket session on the last check Tuesday.